Dr. Peter Block and Dr. Spencer King discuss apixaban vs. warfarin and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndromes (AUGUSTUS ACS—2:22) and ticagrelor monotherapy vs. ticagrelor-plus-aspirin in high-risk percutaneous coronary intervention (TWILIGHT—0:26). Full coverage of TCT 2019 at https://www.acc.org/tct2019  - Acute Coronary Syndromes - 94_5feba5631406a

Day 1 Highlights | TCT 2019

Day 1 Highlights | TCT 2019

9 Views
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

 

Dr. Peter Block and Dr. Spencer King discuss apixaban vs. warfarin and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndromes (AUGUSTUS ACS—2:22) and ticagrelor monotherapy vs. ticagrelor-plus-aspirin in high-risk percutaneous coronary intervention (TWILIGHT—0:26). Full coverage of TCT 2019 at https://www.acc.org/tct2019

 

Up Next Autoplay